#23 TrialNet and T1Detect: Screening for Type 1 and Clinical Trials
Do you or your child have Type 1 Diabetes? Are you wondering if other members of your family, adults or children, may be at risk for developing T1D? Is there a way to screen for that? If they are at risk, is there anything that can be done to delay or prevent the onset of Type 1? These are all fabulous questions and the answers to all of them are discussed in today's episode.
In this episode, I had the pleasure of talking with Frank Martin, Director of Research at JDRF, about their T1Detect program. We also get to hear all about TrialNet from Dr. Michael Haller, professor and Chief of Pediatric Endocrinology at the University of Florida (UF) as well as the principal investigator of the UF TrialNet Clinical Center. See below for descriptions of both with links to their websites to find out more and order your own at-home screening kit.
What is T1Detect?
T1Detect, JDRF’s screening education and awareness program, will arm you with the information you need before and after getting screened for type 1 diabetes (T1D) autoantibodies. Until now, T1D symptoms and a diagnosis often come out of the blue. Today, families can use testing to detect T1D early so they can plan and prepare. With one blood test, anyone at any age can find out—before symptoms even occur—if they are at risk for developing T1D. The test is easy, simple and can help save lives.
Their website:https://www.jdrf.org/t1d-resources/t1detect/
What is TrialNet?
TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams at the forefront of type 1 diabetes (T1D) research. We offer risk screening for relatives of people with T1D and innovative clinical studies testing ways to slow down and prevent disease progression. Our goal: a future without T1D!
Their website: https://www.trialnet.org/